These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16988260

  • 1. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
    Bhattacharjee AK, Izadjoo MJ, Zollinger WD, Nikolich MP, Hoover DL.
    Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
    [Abstract] [Full Text] [Related]

  • 2. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein.
    Bhattacharjee AK, Van de Verg L, Izadjoo MJ, Yuan L, Hadfield TL, Zollinger WD, Hoover DL.
    Infect Immun; 2002 Jul; 70(7):3324-9. PubMed ID: 12065469
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH.
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [Abstract] [Full Text] [Related]

  • 4. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
    Izadjoo MJ, Bhattacharjee AK, Paranavitana CM, Hadfield TL, Hoover DL.
    Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
    [Abstract] [Full Text] [Related]

  • 5. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X, Walters N, Robison A, Trunkle T, Pascual DW.
    Vaccine; 2007 Mar 08; 25(12):2261-8. PubMed ID: 17239499
    [Abstract] [Full Text] [Related]

  • 6. Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models.
    Van De Verg LL, Hartman AB, Bhattacharjee AK, Tall BD, Yuan L, Sasala K, Hadfield TL, Zollinger WD, Hoover DL, Warren RL.
    Infect Immun; 1996 Dec 08; 64(12):5263-8. PubMed ID: 8945575
    [Abstract] [Full Text] [Related]

  • 7. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
    Costa LF, Cabello AL, Batista DFA, Chaki SP, de Figueiredo P, da Paixão TA, Rice-Ficht AC, Ficht TA, Santos RL.
    Microbiol Immunol; 2020 Nov 08; 64(11):730-736. PubMed ID: 32965738
    [Abstract] [Full Text] [Related]

  • 8. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.
    Vaccine; 2014 Nov 20; 32(49):6659-66. PubMed ID: 25240754
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N, Sriranganathan N, Lawler H, Boyle SM, Hiltbold EM, Heid B, Zimmerman K, Witonsky SG.
    Vaccine; 2011 Mar 24; 29(15):2749-55. PubMed ID: 21316499
    [Abstract] [Full Text] [Related]

  • 10. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD.
    Am J Vet Res; 1996 May 24; 57(5):677-83. PubMed ID: 8723881
    [Abstract] [Full Text] [Related]

  • 11. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM, Cassataro J, Vizcaíno N, Zygmunt MS, Cloeckaert A, Bowden RA.
    Microbes Infect; 2003 Feb 24; 5(2):85-93. PubMed ID: 12650766
    [Abstract] [Full Text] [Related]

  • 12. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S.
    Mol Immunol; 2015 Aug 24; 66(2):384-91. PubMed ID: 25968974
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R, Francia M, Ciuchini F.
    Vaccine; 2008 Sep 08; 26(38):4913-7. PubMed ID: 18675869
    [Abstract] [Full Text] [Related]

  • 14. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 08; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 15. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.
    Yang Y, Yin J, Guo D, Lang X, Wang X.
    FEMS Immunol Med Microbiol; 2011 Mar 08; 61(2):159-67. PubMed ID: 21166726
    [Abstract] [Full Text] [Related]

  • 16. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA.
    Infect Immun; 2007 Oct 08; 75(10):4923-32. PubMed ID: 17664263
    [Abstract] [Full Text] [Related]

  • 17. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).
    Hoover DL, Crawford RM, Van De Verg LL, Izadjoo MJ, Bhattacharjee AK, Paranavitana CM, Warren RL, Nikolich MP, Hadfield TL.
    Infect Immun; 1999 Nov 08; 67(11):5877-84. PubMed ID: 10531243
    [Abstract] [Full Text] [Related]

  • 18. Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.
    Delpino MV, Estein SM, Fossati CA, Baldi PC.
    Clin Vaccine Immunol; 2007 Oct 08; 14(10):1296-301. PubMed ID: 17715332
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A, Mahmoud NH, Hammoud R.
    Biologicals; 2012 Mar 08; 40(2):140-5. PubMed ID: 22296786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.